Silvr Blog
Weight Loss Medication Marketing: What You Need to Know Now
Disclaimer: This is not legal advice. Consult with a healthcare attorney about your specific situation.
The Key Points
- Don’t use brand names (Ozempic®, Wegovy®, Mounjaro™, Zepbound™) in marketing unless you offer the FDA-approved versions
- Don’t use generic names (semaglutide, tirzepatide) if offering compounded versions
- Even educational content about these medications carries risk
- Update your website now with compliant terminology
What’s Happening?
- Pharmaceutical companies are filing lawsuits over unauthorized brand name usage
- FDA has removed some medications from the shortage list, changing compounding rules
- Google and social media have created stricter advertising policies
The Risks Are Real
Legal Issues:
- Trademark lawsuits from pharmaceutical companies
- FDA enforcement for improper marketing of compounded medications
- Rejected ads on Google (requires LegitScript certification) and social media platforms
Educational Content Risks:
- Using brand names as SEO tactics while offering alternatives may be considered misleading
- Even purely informational content can trigger trademark concerns
Safe Marketing Alternatives
Use these terms instead:
- “Physician-supervised GLP-1 weight management”
- “Clinician-guided weight loss treatments”
- “Medical weight management solutions”
What To Do Now
- Check your website for medication names (including in meta data)
- Review your ads for non-compliant terms
- Update content to use safe terminology
- Consult your legal team about your specific situation
Tell Us Your Plan
Let us know:
- Which medications you actually offer
- What your legal team recommends
- Your preferred compliant language
We’ll quickly update your online presence based on your guidance.